South Carolina could receive up to $10M in national opioid settlement
COLUMBIA, S.C. (WIS) - South Carolina and nine other states have reached a settlement with several drug manufacturers for their role in the opioid crisis.
South Carolina Attorney General Alan Wilson’s office said the settlement, totaling $720 million from manufacturers Mylan, Hikma, Amneal, Apotex, Indivior, Sun, Alvogen and Zydus. Other states in the settlement include North Carolina, Tennessee, Virginia, New York, Illinois, California, Colorado and Utah.
The attorney general’s office said South Carolina could receive up to $10 million paid out over a pre-determined timeframe.
Wilson added that the settlement funds will help those directly affected by the opioid crisis in South Carolina.
“The opioid epidemic has devastated tens of thousands of families in South Carolina and across the country, and we’ve been working for years to hold the companies responsible for it accountable,” Wilson said in a statement. “The money from these settlements, along with other settlements we’ve announced before, will go toward opioid treatment programs and efforts to prevent future victims of opioid addiction,” he said in a statement.
Most of the settlements allow the states to receive free pharmaceutical products instead of cash settlements.
In addition to the payments, all of the companies except for Indivior are banned from marketing or promoting any opioid products for the next 40 years and from selling or producing any product with more than 40 mg of oxycodone. Each company is also required to have a monitoring system for any suspicious orders.
Indivior can not produce or sell any opioid products for the next 10 years, but can market and sell medications that help with opioid use disorder.
Feel more informed, prepared, and connected with WIS. For more free content like this, subscribe to our email newsletter, and download our apps. Have feedback that can help us improve? Click here.
Copyright 2025 WIS. All rights reserved.